MapLight Therapeutics, Inc. MPLT
10.46
(0.30)
(2.79%)
as of 25 Sep
- Market cap
- $587.7M
- P/E
- 0.0×
Follow MPLT
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
16.52 | 22.91 | 20.01 | 13.22 |
+4 more quarters Free account |
Net Debt/EBITDA |
4.73 | 4.76 | 3.60 | 7.14 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.75 | 0.84 | 0.59 | 1.08 | |
Capex/Depreciation |
0.03 | 0.04 | 0.29 | 0.09 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.99) | (1.13) | (5.44) | (40.22) | |
Cash per Share |
6.71 | 6.85 | 35.15 | 287.15 | |
Shareholders Equity per Share |
7.67 | 8.83 | 52.80 | 295.18 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
7.67 | 8.83 | 52.80 | 295.18 | |
Free Cash Flow |
(44.89) | (51.20) | (47.20) | (31.82) | |
Working Capital |
299.49 | 312.95 | 308.44 | 226.74 | |
Capital Expenditures |
(0.02) | (0.02) | (0.38) | (0.03) | |
Net Current Asset Value |
298.74 | 308.27 | 303.53 | 221.60 | |
| Other line items | |||||
Quick Ratio |
15.79 | 21.71 | 18.80 | 12.24 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.99) | (1.13) | (5.39) | (40.19) | |
Capex per Share |
0.00 | 0.00 | (0.04) | (0.04) | |
Average Payables |
1.98 | — | — | — | |
Average Assets |
184.17 | 209.39 | 239.76 | 128.61 | |
Average Common Equity |
77.34 | — | — | — | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates